Suppr超能文献

头孢洛林用于中枢神经系统和眼部感染:病例系列

Ceftaroline in CNS and ocular infections: a case series.

作者信息

Siegrist Emily A, Sassine Joseph

机构信息

Department of Pharmacy, OU Health, OU Medical Center, 700 NE 13th St., Oklahoma City, OK 73104, USA.

Infectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, 800 Stanton L. Young Blvd, Oklahoma City, OK 73104, USA.

出版信息

JAC Antimicrob Resist. 2024 Jun 17;6(3):dlae095. doi: 10.1093/jacamr/dlae095. eCollection 2024 Jun.

Abstract

BACKGROUND

There are limited data describing outcomes of patients treated with ceftaroline for infections with CNS or ocular involvement.

OBJECTIVES

To describe outcomes of patients treated with ceftaroline for methicillin-resistant staphylococcal infections involving the CNS or eye.

PATIENTS AND METHODS

This was a retrospective review of 10 patients at an academic medical centre who received ceftaroline for CNS or ocular infections.

RESULTS

All patients were treated with ceftaroline as part of a combination for salvage therapy. Four patients died, whereas six patients experienced clinical cure. Only one experienced microbiological recurrence.

CONCLUSIONS

These preliminary data suggest that ceftaroline may be an option for salvage therapy of severe staphylococcal infections when used in combination.

摘要

背景

关于使用头孢洛林治疗中枢神经系统(CNS)或眼部感染患者的疗效数据有限。

目的

描述使用头孢洛林治疗耐甲氧西林葡萄球菌引起的中枢神经系统或眼部感染患者的疗效。

患者与方法

这是一项对某学术医疗中心10例接受头孢洛林治疗中枢神经系统或眼部感染患者的回顾性研究。

结果

所有患者均接受头孢洛林治疗,作为挽救治疗联合方案的一部分。4例患者死亡,6例患者实现临床治愈。仅1例出现微生物学复发。

结论

这些初步数据表明,联合使用时,头孢洛林可能是严重葡萄球菌感染挽救治疗的一种选择。

相似文献

1
Ceftaroline in CNS and ocular infections: a case series.
JAC Antimicrob Resist. 2024 Jun 17;6(3):dlae095. doi: 10.1093/jacamr/dlae095. eCollection 2024 Jun.
2
Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Pharmacotherapy. 2023 Jan;43(1):15-23. doi: 10.1002/phar.2741. Epub 2022 Nov 21.
4
Ceftaroline for Suspected or Confirmed Invasive Methicillin-Resistant Staphylococcus aureus: A Pharmacokinetic Case Series.
Pediatr Crit Care Med. 2018 Jun;19(6):e292-e299. doi: 10.1097/PCC.0000000000001497.
5
Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
J Antimicrob Chemother. 2012 May;67(5):1267-70. doi: 10.1093/jac/dks006. Epub 2012 Feb 6.
7
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Ann Pharmacother. 2016 Dec;50(12):1051-1059. doi: 10.1177/1060028016664361. Epub 2016 Aug 12.
8
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
Int J Antimicrob Agents. 2020 Apr;55(4):105921. doi: 10.1016/j.ijantimicag.2020.105921. Epub 2020 Feb 14.
9
A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant (MRSA) Infections.
Antibiotics (Basel). 2019 Mar 20;8(1):30. doi: 10.3390/antibiotics8010030.

本文引用的文献

1
Population Pharmacokinetic Modeling and Probability of Target Attainment of Ceftaroline in Brain and Soft Tissues.
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0074122. doi: 10.1128/aac.00741-22. Epub 2022 Aug 25.
2
Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline.
Cureus. 2022 Feb 14;14(2):e22216. doi: 10.7759/cureus.22216. eCollection 2022 Feb.
4
Off-label use of ceftaroline fosamil: A systematic review.
Int J Antimicrob Agents. 2019 Nov;54(5):562-571. doi: 10.1016/j.ijantimicag.2019.06.025. Epub 2019 Jul 3.
5
Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes.
Clin Infect Dis. 2020 Feb 3;70(4):566-573. doi: 10.1093/cid/ciz257.
9
Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System.
Drugs. 2017 Aug;77(12):1345-1351. doi: 10.1007/s40265-017-0785-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验